For Institutions
About
LegalZoom.com Inc. will be added to the S&P SmallCap 600® Index, effective February 2, 2026. This addition highlights the company's strong growth, profitability, and durable business model. The information was originally published by LegalZoom via GlobeNewswire.
Amneal Pharmaceuticalsshares rose 3.4% to $14.30 as it prepares to join the S&P SmallCap 600 index, replacing TTM Technologies. Analysts expect passive funds to buy approximately 22.9 million AMRX shares, indicating strong demand. AMRX has a market cap of around $4 billion and has seen a 60% increase in share price over the past year. All five analysts rate the stock as a "buy" with a median price target of $15.
Amneal Pharmaceuticals Inc. will be added to the S&P SmallCap 600 Index, effective January 30, 2026. This inclusion is due to the company's strong operating and financial performance, meeting the index's criteria for market capitalization, liquidity, sector representation, and sustained profitability.
U.S. equity markets have experienced volatility, with initial optimism from Big Tech earnings leading to a high for the S&P 500, followed by a sharp decline due to disappointing earnings and the Fed's steady rates. The S&P SmallCap 600 has outperformed the S&P 500 by 4% in January 2026, indicating a shift towards small-cap stocks. The S&P 500 Equal Weight Index has also outperformed its capitalization-weighted counterpart, reflecting a broader market participation beyond mega-caps. This trend may continue if challenges for Big Tech persist, suggesting a potential shift in investment strategies.
Mid and smallcap stocks have started 2026 poorly, with the midcap index down 4% and many stocks down over 25%. Market sentiment is weak, raising questions about whether to cut losses or seek multi-bagger opportunities. Experts suggest focusing on strong earnings growth and sound governance for stock selection. Anshul Saigal sees potential in sectors like capital goods and energy, while Vinit Sambre advises caution, preferring durable compounders over flashy stories. Both emphasize the importance of patience and discipline in uncertain markets.